You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atypical chronic myeloid leukemia, BCR-ABL1 negative

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Neutrophilic Leukemia Trial in United States (Laboratory Biomarker

Completed
Has Results
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • Chronic Neutrophilic Leukemia
  • Laboratory Biomarker Analysis
  • +3 more
  • Palo Alto, California
  • +6 more
Oct 22, 2020

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Hyperbaric oxygen
  • Rochester, New York
    Wilmot Cancer Institute, University of Rochester
May 16, 2022

Myelodysplastic Syndrome, Myeloproliferative Tumors, Chronic Myelomonocytic Leukemia Trial in United States (other, drug,

Recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • Geriatric assessment (GA) pre-transplant
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 24, 2022

Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Online Mindfulness Meditation
  • Internet-Based Webinars
  • San Francisco, California
    University of California San Francisco
Aug 9, 2022

CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

Recruiting
  • CML, Chronic Phase
  • CML, Accelerated Phase
  • HS-10382(Part 1: Dose escalation)
  • HS-10382(Part 2: Dose expansion)
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Jan 12, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

According to Molecular Identification at Diagnosis

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Next Generation Sequencing (DNA and RNA)
  • (no location specified)
Oct 28, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

"Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

Not yet recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
    • Sohag, Egypt
      Sohag University Hospital
    Sep 14, 2022

    Outcomes in Chronic Myeloid Leukaemia

    Completed
    • Chronic Myeloid Leukaemia
      • York, United Kingdom
        Haematological Malignancy Research Network
      Jun 7, 2023

      Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

      Recruiting
      • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 1, 2022

      Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

      Not yet recruiting
      • Chronic Myelogenous Leukemia - Chronic Phase
      • APN and medical management
      • +3 more
      • Avignon, Provence-Alpes-Côte d'Azur, France
        Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
      Oct 13, 2023

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 15, 2022

      Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

      Completed
      • Chronic Myeloid Leukemia
        • East Hanover, New Jersey
          Novartis
        Nov 20, 2023

        Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

        Recruiting
        • Acute Myeloid Leukemia
        • +4 more
        • Recombinant Interleukin-7
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 26, 2023

        Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

        Not yet recruiting
        • Chronic Myeloid Leukemia, BCR/ABL-Positive
          • Taipei, Taiwan
            National Taiwan University Hospital
          Jul 24, 2022

          Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

          Active, not recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
            • Jena, Germany
              University Hospital Jena
            Jan 17, 2023

            Ponatinib in CML Patients in Chronic Phase

            Recruiting
            • Chronic Myeloid Leukemia, Chronic Phase
            • Therapeutic drug monitoring
            • Molecular Response
            • Cagliari, Italy
            • +4 more
            Nov 3, 2023

            New Diagnosed Chronic Phase Chronic Myeloid Leukemia

            Recruiting
            • Validity and Safety
              • Guangzhou, Guangdong, China
                NanfangH
              Apr 9, 2022

              Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

              Recruiting
              • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
              • +7 more
              • Blinatumomab
              • +3 more
              • Houston, Texas
                M D Anderson Cancer Center
              Dec 31, 2022